A New Stratification Strategy That Identifies a Subset of Class III Patients with an Adverse Prognosis among Children with β Thalassemia Major Undergoing a Matched Related Allogeneic Stem Cell Transplantation
Authors:
- Vikram MathewsVMVikram Mathews
- Biju GeorgeBGBiju George
- Uday DeotareUDUday Deotare
- Kavitha M. LakshmiKLKavitha M. Lakshmi
- Auro ViswabandyaAVAuro Viswabandya
- Dolly DanielDDDolly Daniel
- Mammen ChandyMCMammen Chandy
- Alok SrivastavaASAlok Srivastava
Open Access
- 1 August 2007
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 13 (8) , 889-894
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia – the role of busulfan pharmacokinetics in determining outcomeBone Marrow Transplantation, 2005
- New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 yearsBlood, 2004
- Bone marrow transplantation for β‐thalassaemia major: the UK experience in two paediatric centresBritish Journal of Haematology, 2003
- Marrow transplantation for patients with thalassemia: results in class 3 patientsBlood, 1996
- Bone marrow transplantation in adult thalassemiaBlood, 1992
- Bone Marrow Transplantation in Patients with ThalassemiaNew England Journal of Medicine, 1990
- VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATIONTransplantation, 1987
- MARROW TRANSPLANTATION FOR THALASSAEMIA FOLLOWING BUSULPHAN AND CYCLOPHOSPHAMIDEThe Lancet, 1985
- MARROW TRANSPLANTATION FOR THALASSAEMIAThe Lancet, 1982
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974